Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective

• 主要な著者: Marzieh Zargaran (著者), Fatemeh Soleymani (著者), Saman Ahmad Nasrollahi (著者), Meysam Seyedifar (著者), Mohammad Mehdi Ashrafian Rahaghi (著者)
• フォーマット: 図書
• 出版事項: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background and purpose: Plaque psoriasis is a chronic inflammatory disease with skin manifestations that affect the patients' quality of life negatively. The prevalence of psoriasis is approximately 2-3% worldwide and appears to be still on the increase. Due to the stigma problems, psoriasis ha...